The current results underline a prominent role of IL‐1α and the cytokine antagonist IL‐1Ra but not IL‐1β in the adipose tissue during the early stage of NAFLD. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.